Why Fit-for-Purpose Manufacturing Is Becoming the Defining Strategy in CGT

This first segment of Cell & Gene Live, “Distributed Manufacturing for CGT: Rent, Lease, or Buy in an Era of Overcapacity?,” experts Emily Moran, Founder, 3LB Consulting, LLC and Sugu Patro, Ph.D., Senior Vice President Global Process Development at Kite, a Gilead Company unpacked one of the biggest strategic questions facing CGT companies today: how to make smarter manufacturing decisions in an increasingly complex and overcapacity market. The discussion explored why fit-for-purpose manufacturing matters more than ever. They emphasized that long-term success depends not just on access to capacity, but on aligning technical capabilities, IND readiness, scalability, operational strategy, and commercialization goals from the very beginning.